Next Article in Journal
Are Paclitaxel-Eluting Stents Better in Unprotected Left Main Coronary Artery Disease? Three-Year Clinical and Intravascular Imaging Results From a Randomized Study
Previous Article in Journal
Human Herpesvirus 6 and 7 Reactivation and Disease Activity in Multiple Sclerosis
Article Menu

Article Versions

Export Article

Medicina is published by MDPI from Volume 54 Issue 1 (2018). Articles in this Issue were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence. Articles are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Lithuanian Medical Association, Lithuanian University of Health Sciences, and Vilnius University.
Open AccessArticle
Medicina 2011, 47(10), 76; https://doi.org/10.3390/medicina47100076

The Prevalence of Viral Hepatitis C in Latvia: A Population-Based Study

1
Hepatology Department, State Agency “Infectology Center of Latvia,” Riga, Latvia
2
Riga Stradins University, Latvia 3 State Agency “Infectology Center of Latvia,” Riga, Latvia
4
Infectology and Dermatology Department, Riga Stradins University, Latvia
5
Laboratory, State Agency “Infectology Center of Latvia,” Riga, Latvia
6
Department of Public Health and Epidemiology, Riga Stradins University, Latvia
7
University of Latvia, Riga, Latvia
*
Author to whom correspondence should be addressed.
Received: 17 September 2010 / Accepted: 31 October 2011 / Published: 5 November 2011
PDF [115 KB, uploaded 17 April 2018]

Abstract

Background and Objective. Chronic viral hepatitis C (VHC) is one of the most discussed infectious diseases worldwide. The number of infected persons worldwide is approximately 170 million, and in Europe, it exceeds 9 million. The aim of this study was to determine the prevalence of antibodies to hepatitis C virus (anti- HCV prevalence) and prevalence of HCV viremia (HCV-RNA prevalence) in Latvia.
Material and Methods
. A multistage randomized selection was used. A total of 42 primary care physicians (PCPs) were randomly selected from the register of PCPs from different regions of Latvia. From each PCP register, 60 subjects were selected (1651 individuals in total) and invited for the anti-HCV test with a screening method (ELISA). In case of positive results, antibodies were confirmed by the Western blot test, and all these subjects were tested for HCV-RNA by polymerase chain reaction.
Results
. Of the 1459 subjects tested, 57 were positive for anti-HCV (3.9%; 95% CI 3% to 5%); 35 of them were positive for anti-HCV with a confirmatory test (2.4%; 95% CI, 1.7% to 3.3%): 19 men and 16 women (3.8% and 1.7%, respectively; P=0.011). The results of HCV RNA test were positive in 25 subjects (1.7%; 95% CI, 1.2% to 2.5%): 15 men and 10 women (3% and 1% respectively, P=0.019).
Conclusions
. The prevalence of anti-HCV and HCV-RNA in Latvia was found to be 2.4% and 1.7%, respectively. The prevalence of anti-HCV and HCV-RNA was higher in men than women.
Keywords: hepatitis C; prevalence; population hepatitis C; prevalence; population
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).
SciFeed

Share & Cite This Article

MDPI and ACS Style

Tolmane, I.; Rozentale, B.; Keiss, J.; Arsa, F.; Brigis, G.; Zvaigzne, A. The Prevalence of Viral Hepatitis C in Latvia: A Population-Based Study. Medicina 2011, 47, 76.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Medicina EISSN 1010-660X Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top